Skip to main content Skip to megamenu
Meet us next:   NIH Research Festival 2024  24 September  •  Safety Pharmacology Society 2024  22-24 September  •  Drug Discovery 2024 - ELRIG  2-3 October  •  The Cell & Gene Meeting on the Mesa 2024  7-9 October (in person) & 10-11 October (virtual)  •  Other upcoming events

Brand: Stemfect

Manufacturer: REPROCELL®

The Stemfect RNA Transfection technology provides high efficiency transfection of a variety of RNAs into a range of cell types.

00-0069

A proprietary mixture of lipid components is specifically designed for in vitro RNA transfection, shown to deliver mRNA, siRNA and miRNA. Provides greater than or equal to 90% transfection efficiency of mRNA into a range of cell types with greater than 95% viability – including human ESCs, Jurkat cells, human fibroblasts, and HEK293T cells.